48åã®åµå ð¥ åµååçµ vs åµå·£éå°åå¿
åµååçµã®ããã«æ¥é¢ããã女æ§ããæšæ¥ 48 åã®åµåãæ¡åµããŸããã
圌女ã¯è¥ãããšãŠã现身ã§ãæçµäžé ããããLH/FSH æ¯ã¯ 5 ãè¶ ããAMH å€ã¯ 11 ã§ããã
æçµåšæ 2 æ¥ç®ã®è¶ 鳿³¢æ€æ»ã§ã¯ãéåžžã«å€ãã®èç¶åµè Antral follicle ã確èªãããŸããã
ãããã®æ¡ä»¶ããããå€å¢èæ§åµå·£ãPCOãPolycystic ovary ãšèšºæãããŸããã
ãã®ãããæçµåšæ 2 æ¥ç®ã«æåµèªçºæ³šå°ã§åµå·£åºæ¿ãéå§ããæç¹ã§ããããããåµå·£éå°åºæ¿çå矀ãOHSSãOvarian Hyperstimulation Syndrome ãèµ·ããå¯èœæ§ãããããšããäºåã«åœŒå¥³ãžèª¬æããŸããã
ãŸããããã€ãã®äºé²çãåããããé¡ãããŸããã
OHSS ãšã¯ãè¬å€ã§åµå·£ãåºæ¿ããåŸãäžè¬çãªæ¹ããã匷ãåå¿ãèµ·ãããå€ãã®åµèãçºè²ããç¶æ ãæããŸãã
ãã®çµæãè ¹éšèšæºãè ¹æ°Žãå°¿éæžå°ãé»è§£è³ªãã©ã³ã¹ã®ä¹±ããªã©ãäžé£ã®çççåå¿ãèµ·ãããäžå¿«ãªçç¶ã«ã€ãªãããŸãã
äžè¬çã«ãOHSS ã¯è¥å¹Žã现身äœåãAMH ãé«ããPCO ããã女æ§ã«èµ·ããããããšãããŠããŸãã
ãã®ãããæ²»çäžã«åµèæ°ã 15 åãè¶ ããããŸãã¯ãšã¹ããã²ã³å€ã 3500 ãè¶ ããå Žåã«ã¯ãæ£è ããŸãžæ³šæãä¿ããäºé²çãåã£ãŠããã ããŸãã
ããããåµååçµãäœå€å粟治çãåããæ¹ã«ãšã£ãŠããã®ãããªçç¶ãèµ·ããããšã¯ãåã³ã§ããããäžå®ã§ããããŸãã
åã°ããç¹ã¯ãäžåºŠã§ååãªæ°ã®åµåãæ¡åããåçµä¿åããããèãäœæãããã§ãããããå°æ¥ã®åŠåš æåã«å€§ãã圹ç«ã€ããšã§ãã
äžæ¹ã§ãOHSS ã¯äžå¿«ãªçç¶ãåŒãèµ·ãããå Žåã«ãã£ãŠã¯è ¹æ°ŽãæãåŠçœ®ãå ¥é¢æ²»çãå¿ èŠã«ãªãããšããããŸãã
ãã ããè¿å¹Žãå»ççã§ã¯ OHSS ã«ã€ããŠååãªçè§£ãé²ãã§ããŸãã
ãã®ãããæ£è ããŸã«ã¯ååãªæ å ±ãæäŸããäºé²çãåã£ãŠããã ãããã«ããŠããŸãã
ããšãã°ãã¿ã³ãã¯è³ªãé»è§£è³ªãè£å ããããšã§ãã
ãŸããæåµèªçºã®ããªã¬ãŒæ³šå°ã«ã¯ HCG ã®ä»£ããã« Decapeptyl ã䜿çšããHCG ã®äœ¿çšéãšããã«ãã£ãŠåŒãèµ·ããããäžé£ã®å¯äœçšãæžãããŸãã
OHSS ãããå Žåãæ¡åµåŸãç¶ç¶çãªèгå¯ãšãã©ããŒã¢ãããå¿ èŠã§ãã
åå»ã¯ãå®å šã§çްããããããŠé«ãæåçãç®æããå»çãµãŒãã¹ã®æäŸã«ãåžžã«åªããŠããŸãã
ãïž çããŸã«å¥œåã蚪ããŸãããã« ð
#åµååçµ
#å€å¢èæ§åµå·£
#åµå·£éå°åºæ¿çå矀
